Trial of Tian Jiu Therapy for Allergic Rhinitis

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to investigate the efficacy and safety of Tian Jiu in the treatment of allergic rhinitis compared with placebo and waitlist patients in Hong Kong.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hong Kong Baptist University

Criteria

Inclusion Criteria:

• Positive skin prick tests

• High circulating levels of allergen-specific IgE antibody detected by a specific blood test for allergy called radioallergosorbent test (RAST)]

• Clinical history or allergen to have been identified

• Nasal provocation (test)

Exclusion Criteria:

• Allergic asthma, moderate to severe atopic dermatitis, autoimmune disorders, severe chronic inflammatory diseases, history of anaphylactic reactions, hypersensitivity to cetirizine or related drugs, specific immunotherapy during the past 3 years or planned in the next 2 years, pregnancy or breastfeeding.